Details of Disease
General Information of Disease (ID: DISB9PPH)
Disease Name | Crigler-Najjar syndrome type 2 | |||||
---|---|---|---|---|---|---|
Synonyms |
Crigler-Najjar syndrome, type 2; Crigler Najjar syndrome, type 2; hyperbilirubinemia, Crigler-Najjar type 2; Crigler-Najjar syndrome, type II; bilirubin uridinediphosphate glucuronosyltransferase deficiency type 2; hereditary unconjugated hyperbilirubinemia type 2; UGT deficiency type 2; bilirubin-UGT deficiency type 2; Arias syndrome
|
|||||
Definition |
Type 2 Crigler-Najjar syndrome (CNS2) is a hereditary disorder of bilirubin metabolism characterized by unconjugated hyperbilirubinemia due to reduced and inducible activity of hepatic bilirubin glucuronosyltransferase (GT). CNS2 is a milder form of CNS than CNS1.
|
|||||
Disease Hierarchy | ||||||
Disease Identifiers | ||||||
Molecular Interaction Atlas (MIA) of This Disease
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
This Disease Is Related to 1 DOT Molecule(s)
|
|||||||||||||||||||||||||
This Disease Is Related to 1 DTT Molecule(s)
|
|||||||||||||||||||||||||
This Disease Is Related to 1 DME Molecule(s)
|
|||||||||||||||||||||||||
References